Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Unboosted versus boosted Reyataz maintenance after Reyataz + ritonavir induction in treatment-naive HIV patients
2005-000865-21Phase 4Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in human immunodeficiency virus infection (HIV) comparing Switch to unboosted Reyataz maintenance with Continue boosted Reyataz + Norvir maintenance (2 arms). Started Jul 2005; status: completed.
02
Drugs
atazanavirritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2005-000865-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000865-21.